Caleetech

CaleeTech is a biotech startup specializing in providing novel solutions for obesity and diabetes (diabesity). CaleeTech will improve diabetic parameters and weight management by significantly reducing calory absorption, blood sugar, and fat level without compromising on the patient's quality of life. CaleeTech product is unique, has a high safety profile, is transient and can be used repeatedly. It also addresses market trends – as a quick solution, easy to use, based on natural ingredients and affordable. It was extensively tested on bench and in-vivo with successful recovery and histopathological studies. A clear regulatory strategy is in place after productive meetings with the FDA, and Phase 1 successful clinical trial performed in 2023 in a RAMBAM, diabetes department.